|
US7312044B2
(en)
|
2003-03-07 |
2007-12-25 |
The Trustees Of Columbia University In The City Of New York |
Type 1 ryanodine receptor-based methods
|
|
US7393652B2
(en)
|
2000-05-10 |
2008-07-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
|
|
JP2005503356A
(ja)
*
|
2001-06-07 |
2005-02-03 |
ニューロ３デー |
環状ヌクレオチドホスホジエステラーゼ阻害剤、その製造および使用
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
NZ538749A
(en)
*
|
2002-10-11 |
2006-11-30 |
Actelion Pharmaceuticals Ltd |
Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
|
|
US7544678B2
(en)
|
2002-11-05 |
2009-06-09 |
The Trustees Of Columbia University In The City Of New York |
Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
RU2345985C2
(ru)
*
|
2003-03-26 |
2009-02-10 |
Актелион Фармасьютиклз Лтд. |
Производные тетрагидроизохинолилацетамида в качестве антагонистов орексинового рецептора
|
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
|
ATE383345T1
(de)
|
2003-04-28 |
2008-01-15 |
Actelion Pharmaceuticals Ltd |
Quinoxalin-3-on-verdindungen als orexin-rezeptor antagonisten.
|
|
EP1660454A1
(en)
*
|
2003-07-07 |
2006-05-31 |
Vernalis (R&D) Limited |
Azacyclic compounds as inhibitors of sensory neurone specific channels
|
|
WO2005028438A1
(ja)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
新規ピペリジン誘導体
|
|
US8710045B2
(en)
|
2004-01-22 |
2014-04-29 |
The Trustees Of Columbia University In The City Of New York |
Agents for preventing and treating disorders involving modulation of the ryanodine receptors
|
|
RU2378257C2
(ru)
*
|
2004-03-01 |
2010-01-10 |
Актелион Фармасьютиклз Лтд |
Замещенные производные 1,2,3,4-тетрагидроизохинолина
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
DK1814590T4
(da)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals Llc |
Behandling af obesitet og beslægtede sygdomme.
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
GB0500300D0
(en)
*
|
2005-01-07 |
2005-02-16 |
Ionix Pharmaceuticals Ltd |
Chemical compositions
|
|
US7501395B2
(en)
|
2005-04-25 |
2009-03-10 |
Eisai R & D Management Co., Ltd. |
Method of screening for antianxiety drugs
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
EP1892241B1
(en)
|
2005-05-30 |
2016-03-30 |
Msd K.K. |
Novel piperidine derivative
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
EP2330125A3
(en)
|
2005-08-11 |
2012-12-12 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides with selectable properties
|
|
US7875633B2
(en)
|
2005-08-24 |
2011-01-25 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
WO2007029847A1
(ja)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
二環性芳香族置換ピリドン誘導体
|
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
|
RU2008119687A
(ru)
|
2005-10-21 |
2009-11-27 |
Новартис АГ (CH) |
Комбинации органических соединений
|
|
AU2006307046A1
(en)
|
2005-10-27 |
2007-05-03 |
Msd K.K. |
Novel benzoxathiin derivative
|
|
RU2428423C2
(ru)
|
2005-11-10 |
2011-09-10 |
Баниу Фармасьютикал Ко., Лтд. |
Азазамещенные спиропроизводные
|
|
EA015256B1
(ru)
*
|
2006-03-15 |
2011-06-30 |
Актелион Фармасьютикалз Лтд. |
Производные тетрагидроизохинолина для повышения функции памяти
|
|
US7875636B2
(en)
*
|
2006-04-12 |
2011-01-25 |
Merck Sharp & Dohme Corp. |
Pyridyl amide T-type calcium channel antagonists
|
|
DE602007012072D1
(de)
*
|
2006-04-26 |
2011-03-03 |
Actelion Pharmaceuticals Ltd |
Orantagonisten
|
|
EP2049110B1
(en)
|
2006-07-14 |
2014-08-20 |
Merck Sharp & Dohme Corp. |
Bridged diazepan orexin receptor antagonists
|
|
ATE458740T1
(de)
*
|
2006-08-28 |
2010-03-15 |
Actelion Pharmaceuticals Ltd |
1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
|
|
AU2007300627B2
(en)
|
2006-09-22 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
EP2072519A4
(en)
|
2006-09-28 |
2009-10-21 |
Banyu Pharma Co Ltd |
DIARYLKETIMINDERIVAT
|
|
WO2008053446A2
(en)
|
2006-11-02 |
2008-05-08 |
Piramal Life Sciences Limited |
Benzoxazepine compounds, their preparation and use
|
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
|
AU2007337659A1
(en)
|
2006-12-22 |
2008-07-03 |
Actelion Pharmaceuticals Ltd. |
5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
|
|
EP2123644B1
(en)
|
2007-03-07 |
2014-12-17 |
Takeda Pharmaceutical Company Limited |
Benzoxazepine derivatives and use thereof
|
|
AU2008233662B2
(en)
|
2007-04-02 |
2012-08-23 |
Msd K.K. |
Indoledione derivative
|
|
CA2681163A1
(en)
*
|
2007-04-04 |
2008-10-16 |
F. Hoffmann-La Roche Ag |
Heterocycles as orexin antagonists
|
|
BRPI0811204A8
(pt)
|
2007-05-10 |
2015-09-22 |
Bristol Myers Squibb Co |
Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina
|
|
WO2008143856A1
(en)
|
2007-05-18 |
2008-11-27 |
Merck & Co., Inc. |
Oxo bridged diazepan orexin receptor antagonists
|
|
HRP20120240T1
(hr)
|
2007-05-23 |
2012-04-30 |
Merck Sharp & Dohme Corp. |
Piridil piperidin antagonisti receptora za oreksin
|
|
US8030495B2
(en)
|
2007-05-23 |
2011-10-04 |
Coleman Paul J |
Cyclopropyl pyrrolidine orexin receptor antagonists
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
JP2011505335A
(ja)
*
|
2007-09-11 |
2011-02-24 |
モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト |
治療剤としてのＴＲＰ−６−トリプトレリンおよびＤ−Ｌｅｕ６−ロイプロリドの使用
|
|
KR20100072266A
(ko)
|
2007-10-24 |
2010-06-30 |
머크 샤프 앤드 돔 코포레이션 |
헤테로사이클 페닐 아미드 ｔ-형 칼슘 채널 길항제
|
|
WO2009083903A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Actelion Pharmaceuticals Ltd |
Trisubstituted 3,4-dihydro-1h-isoquinolin compound, process for its preparation, and its use
|
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
|
CA2717384A1
(en)
|
2008-03-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
ES2627848T3
(es)
|
2008-06-04 |
2017-07-31 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
US20110124674A1
(en)
|
2008-07-30 |
2011-05-26 |
Hiroyuki Kishino |
5/5-or 5/6-membered condensed ring cycloalkylamine derivative
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010051206A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US20110245209A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
US20110243940A1
(en)
|
2008-12-16 |
2011-10-06 |
Schering Corporation |
Bicyclic pyranone derivatives and methods of use thereof
|
|
MX2011012584A
(es)
*
|
2009-05-26 |
2012-02-21 |
Exelixis Inc |
Benzoxazepinas como inhibidores de pi3k/m tor, metodos para su uso y fabricación.
|
|
US20120258957A1
(en)
|
2009-11-23 |
2012-10-11 |
Matilda Jane Bingham |
Heterocyclic derivatives
|
|
FR2956401B1
(fr)
|
2010-02-17 |
2012-02-03 |
Servier Lab |
Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
PT2758060T
(pt)
|
2011-09-19 |
2018-01-24 |
ETH Zürich |
Moduladores de ror gama para o tratamento de complicações de diabetes ii
|
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
|
JP6346862B2
(ja)
|
2012-02-07 |
2018-06-20 |
エオラス セラピューティクス， インコーポレイテッド |
オレキシンレセプターアンタゴニストとしての置換プロリン／ピペリジン
|
|
US9440982B2
(en)
|
2012-02-07 |
2016-09-13 |
Eolas Therapeutics, Inc. |
Substituted prolines/piperidines as orexin receptor antagonists
|
|
EP2870144B1
(en)
|
2012-07-03 |
2017-04-19 |
Heptares Therapeutics Limited |
Orexin receptor antagonists
|
|
US20140045746A1
(en)
|
2012-08-02 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
抗糖尿病二環式化合物
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
EP2968439A2
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
EP2781217A1
(en)
|
2013-03-18 |
2014-09-24 |
ETH Zurich |
ROR gamma modulators
|
|
PL3004138T3
(pl)
|
2013-06-05 |
2024-07-29 |
Bausch Health Ireland Limited |
Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
TW201613902A
(en)
|
2014-08-13 |
2016-04-16 |
Eolas Therapeutics Inc |
Difluoropyrrolidines as orexin receptor modulators
|
|
BR112017003745A2
(pt)
|
2014-08-29 |
2017-12-05 |
Tes Pharma S R L |
inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
GB201601301D0
(en)
*
|
2016-01-25 |
2016-03-09 |
Takeda Pharmaceutical |
Novel compounds
|
|
US10894789B2
(en)
|
2016-02-12 |
2021-01-19 |
Astrazeneca Ab |
Halo-substituted piperidines as orexin receptor modulators
|
|
EP3454857A1
(en)
|
2016-05-10 |
2019-03-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
GB201718256D0
(en)
*
|
2017-11-03 |
2017-12-20 |
Heptares Therapeutics Ltd |
Ox1 antagonists
|
|
EP3883930A1
(en)
|
2018-11-20 |
2021-09-29 |
Tes Pharma S.r.l. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
KR102954172B1
(ko)
*
|
2021-03-05 |
2026-04-17 |
상하이 제유 파마슈티칼 컴퍼니 리미티드 |
신규 벤자제핀 융합 고리 유도체
|
|
CN119997982A
(zh)
|
2022-09-09 |
2025-05-13 |
迈里克斯制药有限公司 |
包含nmt抑制剂的抗体药物偶联物及其用途
|
|
WO2025224168A1
(en)
|
2024-04-24 |
2025-10-30 |
Idorsia Pharmaceuticals Ltd |
Aryl sulfone and sulfanone derivatives as orexin receptor modulators
|
|
CN119977904B
(zh)
*
|
2025-02-18 |
2026-05-05 |
合肥工业大学 |
一种苯并氧（碳/硫）氮杂䓬类化合物及其在医学上的应用
|